Archive: 19/08/2015

Safinamide in Parkinson disease: No hint of added benefit

Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of mid- to late-stage Parkinson disease in adults. In combination with levodopa alone or together with other Parkinson ...

Researchers team up to build new schizophrenia collections

Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and The Stanley Center for Psychiatric Research at Broad Institute, together with its international partners, are initiating major new sample collections ...

page 4 from 7